GPT Healthcare Limited has submitted its quarterly compliance certificate under SEBI regulations for the quarter ended March 31, 2026. The filing, dated April 10, 2026, was communicated to both BSE and NSE as part of mandatory regulatory compliance requirements.

Regulatory Compliance Certificate

The certificate was issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, served as the registrar and transfer agent for this compliance requirement.

Certificate Confirmation

MUFG Intime India Private Limited confirmed in their certificate dated April 2, 2026, that no requests for dematerialization or rematerialization of shares were received during the quarter ended March 31, 2026. The certificate was signed by Ashok Shetty, Vice President – Corporate Registry.

Company Details

GPT Healthcare Limited maintains its registered office at GPT Centre, JC-25, Sector III, Salt Lake, Kolkata. The company secretary and compliance officer, Ankur Sharma, digitally signed the submission on April 10, 2026.

This quarterly filing represents routine compliance with SEBI regulations governing depositories and participants, ensuring transparency in share transfer activities for listed companies.

GPT Healthcare Limited has announced the resignation of its Senior Vice President and Chief Business Development Officer, Mr. Debashis Dhar, effective from the close of business hours on April 2, 2026. The resignation was submitted due to personal reasons, marking the departure of a key member of the company's senior management team.

Resignation Details

The company has formally notified both BSE Limited and National Stock Exchange of India Limited about this senior management change in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. Dhar served as one of the Senior Management Personnel (SMP) of the company and will cease to hold this designation from the effective date of his resignation.

Resignation Letter Highlights

In his resignation letter addressed to the Executive Director, Mr. Dhar expressed gratitude to the promoters and leadership team for their continued trust, encouragement, and guidance throughout his tenure. He acknowledged having the privilege of witnessing the organization's growth and evolution, stating that he felt honored to have contributed to the company's journey in his capacity.

Regulatory Compliance

The announcement was made through a formal communication to the stock exchanges, signed by Ankur Sharma, Company Secretary and Compliance Officer. The disclosure includes all required details under Regulation 30 of the Listing Regulations, ensuring full transparency with stakeholders and regulatory authorities.

Company Information

GPT Healthcare Limited is registered with CIN L70101WB1989PLC047402 and has its registered office at GPT Centre, JC-25, Sector III, Salt Lake, Kolkata. The company's shares are traded on BSE Limited under scrip code 544131 and on National Stock Exchange of India Limited under the symbol GPTHEALTH.